{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:23:14Z","timestamp":1765959794479},"reference-count":48,"publisher":"Bentham Science Publishers Ltd.","issue":"1","license":[{"start":{"date-parts":[[2015,2,27]],"date-time":"2015-02-27T00:00:00Z","timestamp":1424995200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["openaidsjournal.com","benthamopen.com"],"crossmark-restriction":true},"short-container-title":["TOAIDJ"],"published-print":{"date-parts":[[2015,2,27]]},"abstract":"<jats:sec><jats:title>Objective :<\/jats:title><jats:p>Compare age-adjusted rates of death due to liver, kidney, and heart diseases during 2009-2011 among US residents diagnosed with HIV infection with those in the general population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods :<\/jats:title><jats:p>Numerators were numbers of records of multiple-cause mortality data from the national vital statistics system with an ICD-10 code for the disease of interest (any mention, not necessarily the underlying cause), divided into those 1) with and 2) without an additional code for HIV infection. Denominators were 1) estimates of persons living with diagnosed HIV infection from national HIV surveillance system data and 2) general population estimates from the US Census Bureau. We compared age-adjusted rates overall (unstratified by sex, race\/ethnicity, or region of residence) and stratified by demographic group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results :<\/jats:title><jats:p>Overall, compared with the general population, persons diagnosed with HIV infection had higher age-adjusted rates of death reported with hepatitis B (rate ratio [RR]=42.6; 95% CI: 34.7-50.7), hepatitis C (RR=19.4; 95% CI: 18.1-20.8), liver disease excluding hepatitis B or C (RR=2.1; 95% CI: 1.8-2.3), kidney disease (RR=2.4; 95% CI: 2.2-2.6), and cardiomyopathy (RR=1.9; 95% CI: 1.6-2.3), but lower rates of death reported with ischemic heart disease (RR=0.6; 95% CI: 0.6-0.7) and heart failure (RR=0.8; 95% CI: 0.6-0.9). However, the differences in rates of death reported with the heart diseases were insignificant in some demographic groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion :<\/jats:title><jats:p>Persons with HIV infection have a higher risk of death with liver and kidney diseases reported as causes than the general population.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1874613601509010014","type":"journal-article","created":{"date-parts":[[2015,3,6]],"date-time":"2015-03-06T11:51:43Z","timestamp":1425642703000},"page":"14-22","update-policy":"http:\/\/dx.doi.org\/10.2174\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Comparison of Rates of Death Having any Death-Certificate Mention of Heart, Kidney, or Liver Disease Among Persons Diagnosed with HIV Infection with those in the General US Population, 2009-2011"],"prefix":"10.2174","volume":"9","author":[{"given":"Y. Omar","family":"Whiteside","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Selik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taoying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra","family":"Karch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela L","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Irene","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"refR1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/aje\/kws321","volume":"177","author":"Wada N","year":"2013","unstructured":"Wada N, Jacobson LP, Cohen M, French A, Phair J, Munoz A. Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodefici-ency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008. Am J Epidemiol 2013; 177 (2) : 116-25.","journal-title":"Am J Epidemiol."},{"key":"refR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2458-11-300","volume":"11","author":"Aldaz P","year":"2011","unstructured":"Aldaz P, Moreno-Iribas C, Egues N , et al. Mortality by causes in HIV-infected adults comparison with the general population. BMC Public Health 2011; 11 : 1-8.","journal-title":"BMC Public Health."},{"key":"refR3","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/01.aids.0000216375.99560.a2","volume":"20","author":"Smit C","year":"2006","unstructured":"Smit C, Geskus R, Walker S , et al. Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion. AIDS 2006; 20 (5) : 741-9.","journal-title":"AIDS."},{"key":"refR4","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/QAD.0b013e328133f285","volume":"21","author":"May M","year":"2007","unstructured":"May M, Sterne JA, Sabin C , et al. Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART collaborative analysis of prospective studies. AIDS 2007; 21 (9) : 1185-97.","journal-title":"AIDS."},{"key":"refR5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1086\/510488","volume":"44","author":"Hessol NA","year":"2007","unstructured":"Hessol NA, Kalinowski A, Benning L , et al. Mortality among participants in the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study. Clin Infect Dis 2007; 44 (2) : 287-94.","journal-title":"Clin Infect Dis."},{"key":"refR6","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/QAI.0b013e3181acb4e5","volume":"51","author":"French AL","year":"2009","unstructured":"French AL, Gawel SH, Hershow R , et al. Trends in mortality and causes of death among women with HIV in the United States a 10-year study. J Acquir Immune Defic Syndr 2009; 51 (4) : 399-406.","journal-title":"J Acquir Immune Defic Syndr."},{"key":"refR7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9343(02)01169-5","volume":"113","author":"Cohen M","year":"2002","unstructured":"Cohen M, French AL, Benning L , et al. Causes of death among women with Human Immunodeficiency Virus infection in the era of combination antiretroviral therapy. Am J Med 2002; 113 (2) : 91-8.","journal-title":"Am J Med."},{"key":"refR8","doi-asserted-by":"crossref","first-page":"E84","DOI":"10.1111\/j.1365-3156.2012.03032.x","volume":"17","author":"Floyd S","year":"2012","unstructured":"Floyd S, Marston M, Baisley K , et al. The effect of antiretroviral therapy provision on all-cause, AIDS and non-AIDS mortality at the population level - a comparative analysis of data from four settings in Southern and East Africa. Trop Med Int Health 2012; 17 (8) : E84-93.","journal-title":"Trop Med Int Health."},{"key":"refR9","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/00126334-200204010-00009","volume":"29","author":"Selik RM","year":"2002","unstructured":"Selik RM, Byers RH, Dworkin MS. Trends in disease reported on, U..; death certificates that mentioned HIV infetion 1987-1999. J Acq Immunde Defic Synd 2002; 29 : 378-87.","journal-title":"J Acq Immunde Defic Synd."},{"key":"refR10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1545109710384505","volume":"10","author":"Adih W","year":"2011","unstructured":"Adih W, Selik RM, Hu X. Trends in Diseases Reported on US Death Certificates That Mentioned HIV Infection, 1996-2006. J Int Assoc Phys AIDS Care 2011; 10 (1) : 5-11.","journal-title":"J Int Assoc Phys AIDS Care."},{"key":"refR11","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jacc.2012.06.063","volume":"61","author":"Boccara F","year":"2013","unstructured":"Boccara F, Lang S, Meuleman C , et al. HIV and Coronary Heart Disease Time for Understanding. J Coll Cardiol 2013; 61 (5) : 511-23.","journal-title":"J Coll Cardiol."},{"key":"refR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2458-12-234","volume":"12","author":"Islam FM","year":"2012","unstructured":"Islam FM, Wu J, Jansson J, Wilson DP. Relative risk of renal disease among people living with HIV a systematic review and meta-analysis. BMC Public Health 2012; 12 (234) : 1-15.","journal-title":"BMC Public Health."},{"key":"refR13","first-page":"339","author":"Coffey S","year":"2011","unstructured":"Coffey S, Glesby M. Coronary Heart Disease Risk Guide for HIV\/AIDS Clinical Care 2011. Rockville MD US Department of Health and Human Services 2011; 339-42.","journal-title":"Rockville MD US Department of Health and Human Services."},{"key":"refR14","first-page":"343","author":"Coffey S","year":"2011","unstructured":"Coffey S, Tiu A. Renal Disease Guide for HIV\/AIDS Clinical Care 2011. Rockville Md US Department of Health and Human Services 2011; 343-56.","journal-title":"Rockville Md US Department of Health and Human Services."},{"key":"refR15","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1086\/375844","volume":"37","author":"Saves M","year":"2003","unstructured":"Saves M, Che\u02c6ne G, Ducimetie`re P , et al. Risk factors for coronary heart disease in patients treated for human immunodeficiency virus compared with the general population. Clin Infect Dis 2003; 37 : 292-8.","journal-title":"Clin Infect Dis."},{"key":"refR16","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/QAD.0b013e328339192f","volume":"24","author":"Lang S","year":"2010","unstructured":"Lang S, Mary-Krause M, Cotte L , et al. Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population. AIDS 2010; 24 : 1228-30.","journal-title":"AIDS."},{"key":"refR17","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1086\/377135","volume":"188","author":"Kellerman SE","year":"2003","unstructured":"Kellerman SE, Hanson DL, McNaghten AD , et al. Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in Human Immunodeficiency Virus-infected subjects. J Infect Dis 2003; 188 : 571-7.","journal-title":"J Infect Dis."},{"key":"refR18","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1001\/archinte.166.15.1632","volume":"166","author":"Weber R","year":"2006","unstructured":"Weber R, Sabin CA, Friis-Moller N , et al. Liver-related deaths in persons infected with the Human Immunodeficiency Virus The DAD Study. Arch Intern Med 2006; 166 : 1632-41.","journal-title":"Arch Intern Med."},{"key":"refR19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/QAI.0000000000000142","volume":"66","author":"Chun HM","year":"2014","unstructured":"Chun HM, Mesner O, Thio CT. HIV outcomes in Hepatitis B virus coinfected individuals on HAART. J Acquir Immune Defic Syndr 2014; 66 (2) : 197-205.","journal-title":"J Acquir Immune Defic Syndr."},{"key":"refR20","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1086\/644771","volume":"49","author":"Chen T-Y Ding El","year":"2009","unstructured":"Chen T-Y Ding El, Seage III GR , et al. Meta-analysis Increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression. Clin Infect Dis 2009; 49 (10) : 1605-5.","journal-title":"Clin Infect Dis."},{"key":"refR21","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1086\/425360","volume":"39","author":"Anderson KB","year":"2004","unstructured":"Anderson KB, Guest JL, Rimland D. Hepatitis C virus coinfection increases mortality in HIV-infected patients in highly active antiretroviral therapy era Data from the HIV Atlanta cohort study. Clin Infect Dis 2004; 39 (10) : 1507-3.","journal-title":"Clin Infect Dis."},{"key":"refR22","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1086\/603558","volume":"49","author":"Piroth L","year":"2009","unstructured":"Piroth L. Coinfection with hepatitis C virus and HIV More than double trouble. Clin Infect Dis 2009; 49 (4) : 623-5.","journal-title":"Clin Infect Dis."},{"key":"refR23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0021-9150(01)00736-5","volume":"162","author":"Seminari E","year":"2002","unstructured":"Seminari E, Pan A, Voltini G , et al. Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitors. Atherosclerosis 2002; 162 : 433-8.","journal-title":"Atherosclerosis."},{"key":"refR24","first-page":"5","volume":"12","author":"Lipshultz SE","year":"2007","unstructured":"Lipshultz SE. The cardiovascular manifestations of HIV infection. Dialogues Cardiovasc Med 2007; 12 (1) : 5.","journal-title":"Dialogues Cardiovasc Med."},{"key":"refR25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1749-6632.2001.tb03900.x","volume":"946","author":"Fisher SD","year":"2001","unstructured":"Fisher SD, Lipshultz SE. Epidemiology of cardiovascular involvement in HIV disease and AIDS. Ann NY Acad Sci 2001; 946 : 13-22.","journal-title":"Ann NY Acad Sci."},{"key":"refR26","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/01.qai.0000179459.31562.16","volume":"41","author":"Crum NF","year":"2006","unstructured":"Crum NF, Riffenburgh RH, Wegner S , et al. Comparisons of causes of death and mortality rates among HIV-infected persons analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr 2006; 41 : 194-200.","journal-title":"J Acquir Immune Defic Syndr."},{"key":"refR27","first-page":"1","volume":"7","author":"Song R","year":"2012","unstructured":"Song R, Green TA. An improved approach to accounting for reporting delay in case surveillance systems. JP J Biostat 2012; 7 (1) : 1-14.","journal-title":"JP J Biostat."},{"key":"refR28","unstructured":"National Center for Health Statistics July 1, 2000-July 2009 revised bridged-race intercensal population estimates. http: \/\/www cdcgov\/nchs\/nvss\/bridged_racehtm Accessed September 9 2012."},{"key":"refR29","unstructured":"National Center for Health Statistics Vintage 2010 bridged-race postcensal population estimates. http: \/\/wwwcdcgov\/nchs\/nvss\/ bridged_racehtm Accessed September 9 2012."},{"key":"refR30","doi-asserted-by":"crossref","unstructured":"Klein RJ, Schoenborn CA, Eds. Age adjustment using the 2000 projected US population. Healthy People Statistical Notes no 20 Hyattsville Maryland National Center for Health Statistics January. 2001.","DOI":"10.1037\/e583772012-001"},{"key":"refR31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1468-1293.2012.01045.x","volume":"14","author":"Beckley M","year":"2013","unstructured":"Beckley M, Marben W, Betz C , et al. End-stage renal disease and dialysis in HIV-positive patients observations from a long-term cohort study with a follow-up of 22 years. HIV Med 2013; 14 : 127-35.","journal-title":"HIV Med."},{"key":"refR32","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1053\/j.ajkd.2007.12.005","volume":"51","author":"Fine DM","year":"2008","unstructured":"Fine DM, Perazella MA, Lucas GM , et al. Kidney biopsy in HIV beyond HIV-associated nephropathy. Am J Kidney Dis 2008; 51 (3) : 504-14.","journal-title":"Am J Kidney Dis."},{"key":"refR33","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s11904-014-0209-9","volume":"11","author":"Kumar N","year":"2014","unstructured":"Kumar N, Perazella MA. Differentiating HIV-associated nephropathy from antiretroviral drug-induced nephropathy A clinical challenge. Curr HIV\/AIDS Rep 2014; 11 (3) : 202-11.","journal-title":"Curr HIV\/AIDS Rep."},{"key":"refR34","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1056\/NEJMoa022048","volume":"348","author":"Bozzette SA","year":"2003","unstructured":"Bozzette SA, Ake CF, Tam HK , et al. Cardiovascular and cerebrovascular events in patients treated for human immuno-deficiency virus infection. N Engl J Med 2003; 348 : 702-10.","journal-title":"N Engl J Med."},{"key":"refR35","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/00126334-200308010-00012","volume":"33","author":"Currier JS","year":"2003","unstructured":"Currier JS, Taylor A, Boyd F , et al. Coronary heart disease in HIVinfected individuals. J Acquir Immune Defic Syndr 2003; 33 : 506-12.","journal-title":"J Acquir Immune Defic Syndr."},{"key":"refR36","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","volume":"349","author":"Friis-Moller N","year":"2003","unstructured":"Friis-Moller N, Sabin CA, Weber R , et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003; 349 : 1993-2003.","journal-title":"N Engl J Med."},{"key":"refR37","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(02)11672-2","volume":"360","author":"Holmberg SD","year":"2002","unstructured":"Holmberg SD, Moorman AC, Williamson JM , et al. Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet 2002; 360 : 1747-8.","journal-title":"Lancet."},{"key":"refR38","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00126334-200208150-00002","volume":"30","author":"Klein D","year":"2002","unstructured":"Klein D, Hurley LB, Quesenberry CP, Sidney S. Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection\u03ba. J Acquir Immune Defic Syndr 2002; 30 : 471-7.","journal-title":"J Acquir Immune Defic Syndr."},{"key":"refR39","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1097\/00002030-200311210-00010","volume":"17","author":"Mary-Krause M","year":"2003","unstructured":"Mary-Krause M, Cotteb L, Simon A, Partisani M, Costagliola D. Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men. AIDS 2003; 17 : 2479-86.","journal-title":"AIDS."},{"key":"refR40","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/HCO.0000000000000041","volume":"29","author":"Ng B","year":"2014","unstructured":"Ng B, MacPherson P, Haddad T. Heart failure in HIV infection focus on the role of atherosclerosis. Curr Opin Cardiol 2014; 29 (2) : 174-9.","journal-title":"Curr Opin Cardiol."},{"key":"refR41","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/clc.4960280311","volume":"28","author":"Blum A","year":"2005","unstructured":"Blum A, Hadas V, Burke M , et al. Viral load of the human immunodeficiency virus could be an independent risk factor for endothelial dysfunction. Clin Cardiol 2005; 28 : 149-53.","journal-title":"Clin Cardiol."},{"key":"refR42","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1086\/503261","volume":"42","author":"Solages A","year":"2006","unstructured":"Solages A, Vita JA, Thornton DJ , et al. Endothelial function in HIV-infected persons. Clin Infect Dis 2006; 42 : 1325-32.","journal-title":"Clin Infect Dis."},{"key":"refR43","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1053\/pcad.2000.9031","volume":"43","author":"Lewis W","year":"2000","unstructured":"Lewis W. Cardiomyopathy in AIDS a pathophysiological perspective. Prog Cardiovasc Dis 2000; 43 : 151-70.","journal-title":"Prog Cardiovasc Dis."},{"key":"refR44","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1749-6632.2001.tb03902.x","volume":"946","author":"Lewis W","year":"2001","unstructured":"Lewis W. AIDS cardiomyopathy physiological, molecular, and biochemical studies in the transgenic mouse. Ann N Y Acad Sci 2001; 946 : 46-56.","journal-title":"Ann N Y Acad Sci."},{"key":"refR45","first-page":"39","volume":"10","year":"1993","unstructured":"World Health Organization.Rules and guidelines for mortality and morbidity coding. In International statistical classification of diseases and related health problems. Geneva World Health Organization 1993; 10 (2) : 39.","journal-title":"Geneva World Health Organization."},{"key":"refR46","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/EDE.0b013e31821b5332","volume":"22","author":"Kowalska JD","year":"2011","unstructured":"Kowalska JD, Friis-Moller N, Kirk O , et al. The Coding Causes of Death in HIV (CoDe) Project initial results and evaluation of methodology. Epidemiology 2011; 22 : 516-23.","journal-title":"Epidemiology."},{"key":"refR47","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0002-9629(15)41698-2","volume":"311","author":"Bernicker EH","year":"1996","unstructured":"Bernicker EH, Atmar RL, Schafner DL , et al. Unanticipated diagnoses found at autopsy at an urban public teaching hospital. Am J Med Sci 1996; 311 : 215-0.","journal-title":"Am J Med Sci."},{"key":"refR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2014.04.155","volume":"175","author":"Esc\u00e1rega RO","year":"2014","unstructured":"Esc\u00e1rega RO, Franco JJ, Mani BC , et al. Cardiovascular disease in patients with chronic human immunodeficiency virus infection. Int J Cardiol 2014; 175 : 1-7.","journal-title":"Int J Cardiol."}],"container-title":["The Open AIDS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/openaidsjournal.com\/VOLUME\/9\/PAGE\/14\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T15:42:57Z","timestamp":1598802177000},"score":1,"resource":{"primary":{"URL":"https:\/\/openaidsjournal.com\/VOLUME\/9\/PAGE\/14\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,27]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2,27]]}},"alternative-id":["TOAIDJ-9-14"],"URL":"https:\/\/doi.org\/10.2174\/1874613601509010014","relation":{},"ISSN":["1874-6136"],"issn-type":[{"value":"1874-6136","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2,27]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2014-11-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-1-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-2-5","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-2-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}